Adjuvant Treatment of Real World Melanoma Patients with Nivolumab: 3-year Results of the German, prospective, non-interventional NICO Study

被引：0

作者：

Weichenthal, M. ^{[1
]}

Gutzmer, R. ^{[2
]}

Eigentler, T. ^{[3
]}

Sickmann, T. ^{[4
]}

Goeppner, D. ^{[5
]}

Herber, M. ^{[4
]}

Herbst, R. ^{[6
]}

Hollburg, W. ^{[7
]}

Kreuter, A. ^{[8
]}

Loquai, C. ^{[9
]}

Pfoehler, C. ^{[10
]}

Sachse, M. M. ^{[11
]}

Tratzmiller, S. ^{[12
]}

Ugurel, S. ^{[13
]}

Utikal, J. S. ^{[14
]}

von Wasielewski, I. ^{[15
]}

Schadendorf, D. ^{[13
]}

Mohr, P. ^{[16
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Kiel, Germany

[2] Univ Klinikum Ruhr Univ, Muhlenkreiskliniken AoR, Minden, Germany

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Bristol Myers Squibb, Munich, Germany

[5] Justus Liebig Univ Giessen, Giessen, Germany

[6] Helios Klinikum Erfurt, Erfurt, Germany

[7] HTZ Hamburg Tabea HOPA, Hamburg, Germany

[8] Helios St Elisabeth Klin Oberhausen, Oberhausen, Germany

[9] Uniklin Mainz, Mainz, Germany

[10] Univ Klinikum Saarlandes, Homburg, Germany

[11] Klinikum Bremerhaven, Bremerhaven, Germany

[12] Stadt Klinikum Karlsruhe, Karlsruhe, Germany

[13] Univ Klinikum Essen, Essen, Germany

[14] Ruprecht Karl Univ Heidelberg, Univ Klinikum Mannheim, Mannheim, Germany

[15] Hannover Med Sch, Haut Tumor Zentrum, Hannover, Germany

[16] Elbe Kliniken Buxtehude, Buxtehude, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

FV24

引用

页码：19 / 20

页数：2

共 50 条

[1] Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
Gutzmer, R.
Weichenthal, M.
Eigentler, T.
Grimmelmann, I.
Sickmann, T.
Zimmer, L.
Livingstone, E.
Ugurel, S.
Utikal, J. S.
Muller, V.
Goppner, D.
Herbst, R.
Kreuter, A.
Pfohler, C.
Hollburg, W.
Loquai, C.
Kahler, K.
Mohr, P.
Schadendorf, D.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 18 - 19
[2] Use of nivolumab (NIVO) in adjuvant melanoma patients: real world data from NICO, a national prospective non-interventional study
Gutzmer, Ralf
Mohr, Peter
Eigentler, Thomas
Grimmelmann, Imke
Zimmer, Lisa
Livingstone, Elisabeth
Ugurel, Selma
Utikal, Jochen
Mueller, Verena
Goeppner, Daniela
Herbst, Rudolf
Kreuter, Alexander
Pfoehler, Claudia
Hollburg, Wiebke
Carmen, Loquai
Herber, Martin
Kaehler, Katharina C.
Weichenthal, Michael
Schadendorf, Dirk
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 236 - 237
[3] Nico: Real World Evidence in Advanced Melanoma; A National Prospective Non-Interventional Study of Nivolumab Monotherapy or in Combination with Ipilimumab in Patients with Advanced Melanoma and in Patients with Adjuvant Nivolumab Therapy
Schadendorf, Dirk
Eigertler, Thomas
Mohr, Peter
Weichenthal, Michael
Goeppner, Daniela
Haferkamp, Sebastian
Herber, Martin
Meier, Friedegund
Meiss, Frank
Pfoehler, Claudia
Schneider, Stefan W.
Terheyden, Patrick
Ulrich, Lens
Utikal, Jochen
Weishaupt, Carsten
Gutzmer, Ralf
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 175 - 175
[4] Real-world evidence in melanoma: A national, prospective, non-interventional study (NIS) of nivolumab monotherapy or in combination with ipilimumab in patients with advanced (unresected or metastatic) melanoma (NICO)
Eigentler, T.
Gutzmer, R.
Mohr, P.
Kaatz, M.
Pfohler, C.
Terheyden, P.
Ulrich, J.
Utikal, J.
Zimmer, L.
Schadendorf, D.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 159 - 159
[5] Real-world Data on advanced Melanoma: First Data from a national, prospective, non-interventional Study of Nivolumab in Combination with Ipilimumab or as Nivolumab Monotherapy (NICO)
Weichenthal, M.
Gutzmer, R.
Eigentler, T.
Mohr, P.
Goeppner, D.
Haferkamp, S.
Herber, M.
Herbst, R.
Meier, F.
Meiss, F.
Pfoehler, C.
Schneider, S. W.
Terheyden, P.
Ulrich, J.
Utikal, J.
Weishaupt, C.
Welzel, J.
Schadendorf, D.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 5 - 6
[6] NICO - a national prospective non-interventional Study (NIS) with Nivolumab as Monotherapy or in combination with Ipilimumab in Patients with advanced (inoperable or metastatic) Melanoma to collect real-world data
Gutzmer, R.
Eigentler, T.
Mohr, P.
Becker, S.
Haferkamp, S.
Meiss, F.
Pfoehler, C.
Satzger, I.
Schneider, S. W.
Terheyden, P.
Ulrich, J.
Utikal, J.
Weichenthal, M.
Weishaupt, C.
Zimmer, L.
Schadendorf, D.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 79 - 79
[7] Real World Data on the Use of Nivolumab (Nivo) as Monotherapy or in Combination with Ipilimumab (Nivo plus Ipi) in the Treatment of advanced Melanoma: Interim Results of the non-interventional Study NICO
Ugurel, S.
Satzger, I.
Eigentler, T.
Mohr, P.
Goeppner, D.
Herber, M.
Herbst, R.
Kaehler, K. C.
Meier, F.
Meiss, F.
Pfoehler, C.
Sachse, M. M.
Schneider, S. W.
Terheyden, P.
Ulrich, J.
Utikal, J. S.
Welzel, J.
Schadendorf, D.
Gutzmer, R.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 69 - 70
[8] Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO
Gutzmer, R.
Eigentler, T.
Mohr, P.
Weichenthal, M.
Duecker, P.
Gebhardt, C.
Goeppner, D.
Haferkamp, S.
Kaehler, K.
Meier, F.
Pfoehler, C.
Satzger, I.
Sickmann, T.
Sindrilaru, A.
Terheyden, P.
Ugurel, S.
Ulrich, J.
Utikal, J.
Weishaupt, C.
Schadendorf, D.
ANNALS OF ONCOLOGY, 2020, 31 : S746 - S747
[9] Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab
Gerdes, S.
Asadullah, K.
Hoffmann, M.
Korge, B.
Mortazawi, D.
Wegner, S.
Personke, Y.
Gomez, M.
Sticherling, M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : 1568 - 1577
[10] HANNA - real-world evidence from a German, prospective, non-interventional study with nivolumab in patients with squamous cell carcinoma of the head and neck (SCCHN)
von der Heyde, E.
Welslau, M.
Gauler, T.
Hahn, D.
Wittekindt, C.
Mueller-Huesmann, H.
Bockmuehl, U.
Mauz, P. -S.
Waldenberger, D.
Dietz, A.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 57 - 57

← 1 2 3 4 5 →